Generation Bio Co.

Ownership Transactions Reported by 19 Insiders

Symbol
GBIO on Nasdaq
Industry
Pharmaceutical Preparations
Location
301 Binney Street, Cambridge, Massachusetts

Insiders trading volume in the past year

Generation Bio Co. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Atlas Venture Fund X, L.P. 10%+ Owner $15.8 M Sep 17, 2021
Geoff Mcdonough PRESIDENT AND CEO, Director $9.29 M Apr 15, 2024
Matthew Stanton Chief Scientific Officer $1.71 M Apr 15, 2024
Charles A. Rowland Jr Director $1.3 M +$478 K +58.3% Jun 6, 2024
Phillip Samayoa Chief Strategy Officer $1.2 M -$3.96 K -0.33% Apr 15, 2024
Matthew Norkunas Chief Financial Officer $951 K Apr 15, 2024
Antoinette Paone Chief Operating Officer $840 K -$37.7 K -4.3% Jul 1, 2024
Douglas Kerr Chief Medical Officer $733 K Jan 29, 2024
Donald William Nicholson Director $683 K +$144 K +26.7% Jun 6, 2024
Yalonda Howze Chief Legal Officer $657 K Apr 15, 2024
Anthony G. Quinn Director $584 K +$125 K +27.2% Jun 6, 2024
Dannielle Appelhans Director $314 K +$32.3 K +11.5% Jun 6, 2024
Jeffrey M. Jonas Director $275 K Jun 6, 2024
Ronald Harold Wilfred Cooper Director $275 K Jun 6, 2024
Catherine Stehman-Breen Director $275 K Jun 6, 2024
Gustav Christensen Director $275 K Jun 6, 2024
Jason P. Rhodes Director $275 K Jun 6, 2024
Tracy Zimmermann Chief Development Officer $93.4 K Jan 29, 2024
Atlas Venture Associates X, L.P. 10%+ Owner $1.16 K Sep 27, 2021

Recent Insider Transactions by Companies or Individuals for Generation Bio Co.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership